Complementary, alternative medicine may have higher risk for excessive bleeding during breast cancer surgery
the ONA take:
The popularity and increased use of complementary and alternative medicine (CAM) by cancer patients is something that oncologists should be aware of because of the side effects that can occur and subsequently impact treatment for the disease.
In a recent study published in the journal Integrative Cancer Therapies, researchers from institutions in Washington state looked at a sample of 98 women with breast cancer who received integrative (CAM) therapy and compared them to a larger group of women with similar demographics and disease characteristics, but who did not receive CAM.
The results of the study, which focused on women with breast cancer who reported both an initial surgery for their cancer and who also reported using garlic, ginseng, cranberry, gingko, vitamin E, and fish or flaxseed oil, at the time of their initial surgery, showed that 16% reported using one or more herbs or supplements thought to potentially increase their risk for adverse bleeding-related outcomes at the time of their primary surgical treatment.
This number does not include the 22% of patients who reported using fish or flaxseed oil, which were once thought to increase the risk for excessive bleeding but have since been proven safe in that regard. The authors cautioned that further research is needed to better understand the risks associated with use of a variety of herbs and supplements among women approaching surgery.
Breast cancer patients using herbal supplements had increased risk for adverse bleeding-related outcomes.
Sign Up for Free e-newsletters
- Chemotherapy-Related Fatigue Linked to Levothyroxine Use in Breast Cancer
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Adjuvant Vemurafenib Does Not Improve Disease-Free Survival in Melanoma
- Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
- Zinc Sulfate Improves Chemotherapy-Induced Mucositis Outcomes in Leukemia
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|